搜索范围
文件类型
75-65-0
应用筛选条件
关键词:'75-65-0'
显示 1-30 #N/A 714 条结果 关于 "75-65-0" 范围 技术文档
Milli-Q® IX 7003/05/10/15 Water Purification system - Chinese
Gard®（ 滤柱）（天） 365 1 - 365
IPAK Gard®（ 滤柱）（L） 30000 27000-30000
（水箱）空气过滤器（天） 365 1 - 365
水箱空 (%) 0 0 - 50
Millipak® （0.22 μm过滤器）（天） 182 30 - 182
Millipak® Gold（0.22 μm无菌过滤器）（天） 182 30 - 182
建议每年清洁一次进水滤网以免阻塞
PLA & PLGA Polymer Portfolio for Peptide & Small Molecule Formulation
0.40-0.50 42-65
EXPANSORB® DLG 65-3A 5.43121 PLGA 65/35 COOH 0.25-0.35 15-40
EXPANSORB® DLG 65-6A 5.43122 PLGA 65/35 COOH 0.50-0.65 45-85
EXPANSORB® DLG 75-2A 5.43124 PLGA 75/25 COOH 0.08-
Ramipril and Related Substances - From HPLC to UHPLC
0.0 90 10
1.66 90 10
1.93 75 25
5.54 65 35
8.31 25 75
11.08 25 75
0
60
0 2 4 6 8 10 12
In
te
Retention time
Product Information Sheet-11417991001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
Product Information Sheet-11417959001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
Product Information Sheet - 11417983001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
Steam-in-Place Sterilization of Filtration Trains containing Milligard®PES Prefilters
sterilization.
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
0 605 10 15 20 25 30 35 40 45 50 55 65 70 75 80 85 90 95
T
em
DNA Modifying Enzymes
25-50 50-75 0-10 25-50 100
R3635 Bsm I GAATGCNØN 65 °C 0-10 50-75 0-10 25-50 100
R2634 BssH II GØCGCGC 50 °C 100 100 75-100 100 75-100
R4253 BstE II GØGTNACC 60 °C 75-100 100 25-50 50-75 50-75
R1761 Cfo
The Effective Use of Protein Kinase Inhibitors
(1
0
µM
)
PP
1
(1
0
µM
)
PP
2
(1
0
µM
)
PP
3
(1
0
µM
)
SU
6
65
6
(S
9
69
2)
(1
0
SMC®Plate Washer Evaluation Kit
A 68 65 86 57 71 79 61 79 59 69 59 82 70 10 14
B 79 55 63 62 60 60 52 49 64 61 43 70 60 9 16
C 87 75 78 59 70
Product Information Sheet - 11082035001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
Product Information Sheet - 11417967001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
Product Information Sheet - 11417975001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
Prohibited Substances Korean
Carbon disulfide; 75-15-0] 및 이를 0.1% 이상 함유한 혼합물질
급성 흡입독성,
인화성 액체
2019-5 산화에틸렌[Ethylene oxide; 75-21-8] 및 이를 0.1% 이상 함유한 혼합물질
급성 흡입독성,
인화성 가스
2019-6 메틸디클로로실란[Methyldichlorosilane ; 75-54-7] 및 이를 10%
Calcium carbonate as a replacement for titanium dioxide in coating
105
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
b* L*a*
a*
a
nd
b
*
L*
L = 100
white
yellow
+b
green
-a
red
+a
blue
-b
L = 0
black
UHPLC 2 - Guidelines for high throughput separations
2
0 . 7 2
0 . 8 5
0 . 9 7
1 . 0 9
NIP Mix 4
PHBA Ester Mix
Bruker Order No. H5799
T im e
0 . 0 0 0 . 2
The Effective Use of Protein Kinase Inhibitors
(1
0
µM
)
PP
1
(1
0
µM
)
PP
2
(1
0
µM
)
PP
3
(1
0
µM
)
SU
6
65
6
(S
9
69
2)
(1
0
PureFlex™ and PureFlex™ Plus White Paper
butanone(TIC) 75-97-8 31
2-pentanone 107-87-9 17
1N HCl no
acetone 67-64-1 22
Acetaldehyde (TIC) 75-7-0 60
Tert-butyl alcohol 75-65-0 18
1N HCl yes
acetone 67-64-1 50
tert-butyl alcohol 75-65-0 98
Acetaldehyde
Product Information Sheet - P5380
pH 11.5 ≈ 0%
Effect of temperature at constant pH (pH = 8.5),
for 10 minutes (activity remaining):19
• 30 °C ≈ 25%
• 40 °C ≈ 40%
• 50
Novabiochem Innovations 02/04
BBoorroonniicc aacciidd bb
AArryyll--BBrr % Yield % Yield
11 79 70
22 75 65
33 84 74
44 95 82
55 97 75
66 97 67
77 84 80
Merck Biosciences
Application compilation - Pharma campaign
Flow µL/min
0.0 65 55 104
Bulletin - 857340P
Transition temp. No data
CAS 799268-75-0 CMC No data
Synonyms LPA1/LPA3 competitive antagonist;
VPC 32183
pKa No data
Molec. Formula C33H54N3O6P TLC mobile phase C:M:W*, 65:35:8, v/v
MW 619.772 Exact
Polar Hydrophilic Compounds PartII Sodium Cyclamate MM
psi)
65
80
35
50
65
nt
en
si
ty
(m
A
U
)
5
20
35In
Chromatographic Data
No. Compound Retention Time (min) Theoretical plates
Montage Albumin Deplete Kit
Radial Immunodiffusion Assay
Human Plasma Albumin
Volume (µL) Depletion (%)
20 85
50 75
75 65
100 58
Performance
Depletion of Albumin from Human Plasma
Figure 1. Human plasma sample
Microwave accelerated Suzuki couplings employing a polymer-supported phosphine
BBoorroonniicc aacciidd bb
AArryyll--BBrr % Yield % Yield
11 79 70
22 75 65
33 84 74
44 95 82
55 97 75
66 97 67
77 84 80
In Vitro Evaluation of Novel Silica Materials to Enhance the Dissolution Rate of Fenofibrate and Itraconazole
silica (26 week)
65 70 75 80 85 90 95
Temperature (°C)
Fenofibrate (crystalline)
Drug-loaded silica (initial)
Drug-loaded silica (26 week)
0
20
40
60
80
100
0 30 60
Prohibited Product List Korean
75-15-0 1차 2020-08-25
1.02211.1000 102211 CARBON DISULFIDE EMPLURA® 1 L 75-15-0 1차 2020-08-25
1.02214.1000 102214 CARBON DISULFIDE
Bulletin - 857365P
AE, Chun J (2006) Emerging medicinal roles for lysophospholipid signaling. Trends Molec Med 12(2): 65-75
• Davis MD et al (2005) Spingosine-1-phosphate analogs as receptor antagonists. J Biol Chem 280(11
Corning Synthemax-R Surface for Research
(+7) 495 621 6037
Singapore
Tel: (+65) 6779 1200
Fax: (+65) 6779 1822
Slovakia
Tel: (+421) 255 571 562
Fax: (+421) 255 571 564
South Africa
Free Tel: 0800 1100 75
Free Fax: 0800 1100 79
Tel: (+27) 11
Impurities & Related Compounds: Reference Materials
TRICHLOROETHYLENE
108-10-1
108-10-1
75-09-2
108-38-3
127-19-5
127-19-5
95-47-6
109-60-4
109-60-4
110-86-1
75-65-0
75-65-0
1634-04-4
1634-04-4
109-99-9
109
1/24